You are here: Industry Insights > COVID-19 vaccine

News List

Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet prnasia
February 01, 2021
Clover Biopharmaceuticals today announced that the data from its Phase 1 clinical trial evaluating the safety and immunogenicity of its protein-based adjuvanted S-Trimer COVID-19 vaccine candidates was published in the peer-reviewed journal, The Lancet.
CEPI offers $140 million to support research on COVID-19 vaccines europeanpharmaceuticalreview
February 01, 2021
CEPI has opened a new funding opportunity, providing up to $140 million to support additional clinical research on COVID-19 vaccines.
NHS has offered COVID-19 vaccine to all eligible care homes in England pharmatimes
February 01, 2021
The NHS has now offered COVID-19 vaccinations to residents at all eligible care homes in England, according to official figures.
Novartis Inks Contract Manufacturing Deal for Pfizer-BioNTech COVID-19 Vaccine contractpharma
February 01, 2021
Novartis to leverage manufacturing capacity and capabilities to address pandemic, supporting global supply of COVID-19 vaccine.
AstraZeneca’s Covid-19 vaccine gets EUA in Philippines pharmaceutical-technology
February 01, 2021
AstraZeneca has obtained emergency use authorisation (EUA) from the Philippines Food and Drug Administration (FDA) for its Covid-19 vaccine, granted following a detailed review by medical and regulatory experts in the country.
mRNA COVID-19 vaccine approvals likely to increase development and approvals in oncology: GlobalData expresspharma
February 01, 2021
The rapid advancement of mRNA vaccine development in recent months – in an attempt to halt the COVID-19 pandemic – is expected to continue to break barriers in the pharma industry, with the oncology market being the most likely to benefit, says GlobalData
Serum Institute of India seeks permission for local trials of Novavax vaccine expresspharma
February 01, 2021
Serum Institute of India (SII) has applied to the DCGI to conduct a small domestic trial of Novavax’s COVID-19 vaccine, which was found to be 89.3 per cent effective in a UK trial.
COVID-19 vaccines supply may meet, even exceed demand in India by third quarter: AstraZeneca India Head expresspharma
February 01, 2021
For any vaccine to be meaningful in the current pandemic, it has to be made available broadly, equitably and timely, he said.
J&J’s COVID-19 vaccine best used to curb outbreak, Novavax’s vaccine for overall protection: GlobalData expresspharma
February 01, 2021
As countries increasingly have weapons against COVID-19 in their armamentarium, increased scrutiny will be placed on the fifth, sixth, and later vaccines to enter the market.
AstraZeneca-Oxford COVID-19 vaccine approved in EU expresspharma
February 01, 2021
The AstraZeneca vaccine demonstrated efficacy of around 60 per cent in the trials on which the decision was based, the European Medicines Agency (EMA) said in a statement.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page